+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Gene Therapy Market by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy), Vector Type (Non-viral Vectors, Viral Vectors), Application - Forecast 2024-2030- Product Image
Global Gene Therapy Market by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy), Vector Type (Non-viral Vectors, Viral Vectors), Application - Forecast 2024-2030- Product Image
Sale

Global Gene Therapy Market by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy), Vector Type (Non-viral Vectors, Viral Vectors), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4858031
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gene Therapy Market size was estimated at USD 5.67 billion in 2023, USD 7.05 billion in 2024, and is expected to grow at a CAGR of 27.15% to reach USD 30.48 billion by 2030.

Gene therapy is a medical procedure that introduces, alters, or corrects genetic material within an individual's cells to treat or prevent disease. The primary purpose of gene therapy is to address genetic disorders by replacing or repairing faulty genes, introducing therapeutic genes, or regulating the expression of genes. This field holds great promise for treating various genetic and acquired diseases at their root cause. Several factors are contributing to the growth of the gene therapy market, including an increase in the prevalence of chronic conditions, a rise in acceptance of gene therapy treatment, a surge in clinical trials, and escalated R&D expenditure in the pharmaceutical sector.

However, the cost of these therapies is exceptionally high, accompanied by a complex and lengthy development process. Additionally, concerns regarding off-target effects, immunogenicity, and long-term safety may hamper its market demand. Moreover, advanced technology development has opened several previously inaccessible gene editing and therapy frontiers. The gene therapy market is anticipated to grow further due to regulatory authorities' rising approval of gene therapy products, which brought forth many potential opportunities with targeted disease treatments.

Regional Insights

The Americas has a significant landscape in gene therapy owing to rising research and innovation with significant investments in this domain. The gene therapy market has witnessed exponential growth, mainly due to the improved prevalence of chronic diseases, availability of funding for genetic research, a strong presence of industry players, and FDA approvals that significantly impact gene therapy trends. The European region shows considerable growth in the gene therapy sector due to advanced research in gene therapy due to its well-established pharmaceutical companies. The European Union invests heavily in healthcare research, including gene therapy.

Countries lead in therapeutic clinical trials, particularly in oncology, cardiovascular, and inherited diseases. The Asia-Pacific region is a rapidly emerging market in the arena of gene therapy. The surge in clinical trials spurred by its burgeoning biotech sector and substantial government funding, fast-track innovative gene therapy research is further fueled by expanded market demand. Overall, the APAC region's growth in gene therapy is driven by a combination of large patient populations, growing healthcare expenditure, and evolving regulatory environments.

Market Trends by Segment

  • Type: Prevalence of cancer gene therapy for cancer treatment
  • Vector Type: Significant utilization of viral vector providing higher efficiency in delivering genes into cells
  • Application: Potential adoption of gene therapy as a revolutionary approach to treating cardiovascular diseases

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing

Charles River introduced the Lentivation Platform to expedite the development of lentiviral-based gene therapies. This innovative platform empowers scientists with enhanced control over transgene expression, ensuring better safety and efficacy for gene therapy products. With the Lentivation Platform, researchers can stress the importance of transgene regulation, leading to improved outcomes in gene therapy treatments. This technology represents a significant advancement in gene therapy, offering a promising solution for addressing various genetic disorders and diseases.

Laurus to launch Gene Therapy Assets in India

Laurus Labs introduced gene therapy-based assets in India, offering treatment options for retinal and muscular dystrophy. This development signifies the entry of the genetic medicine market in India, with industry experts anticipating significant opportunities in the field of gene therapy.

Bluebird bio Lays Gene Therapy Launch Groundwork As Sickle Cell Application Nears

Bluebird Bio launched Zynteglo, its dual gene therapy. Gene therapy is a rapidly expanding medical research and treatment field, with Zynteglo offering potential cures for previously untreatable genetic diseases. This groundbreaking therapy brings hope to patients and opens up new possibilities in the fight against genetic disorders.

Key Company Profiles

The report delves into recent significant developments in the Gene Therapy Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., Adaptimmune Therapeutics PLC, AGC Biologics., Alnylam Pharmaceuticals, Inc., American Gene Technologies Inc., Amgen Inc., AnGes, Inc., Applied Genetic Technologies Corporation, Astellas Gene Therapies, Biogen Inc., Bluebird Bio, Inc., Cellectis, Inc., Editas Medicine, Inc., Human Stem Cells Institute, Ionis Pharmaceuticals, Inc., Merck & Co., Inc., Mustang Bio, Novartis AG, Orchard Therapeutics PLC, Poseida Therapeutics, Inc., Sangamo Therapeutics, Inc., Sarepta Therapeutics, Inc., Shenzhen SiBiono GeneTech Co. Ltd., Spark Therapeutics, Inc., and Uniqure N.V.

This research report offers invaluable insights into various crucial aspects of the Gene Therapy Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Chronic Diseases and Upsurge in Number of Gene Therapy Treatment Centers
5.1.1.2. Government Support and Ethical Acceptance of Gene Therapy For Treatments
5.1.2. Restraints
5.1.2.1. High Costs Associated with Gene Therapies
5.1.3. Opportunities
5.1.3.1. Ongoing Research & Development in Orphan Diseases and Advancements in Gene Therapy
5.1.3.2. Innovative Payment Models and Favorable Regulatory Approvals
5.1.4. Challenges
5.1.4.1. Potential Harmful Effects and Moral Concerns Regarding New Gene Therapy
5.2. Market Segmentation Analysis
5.2.1. Type: Prevalence of cancer gene therapy for cancer treatment
5.2.2. Vector Type: Significant utilization of viral vector providing higher efficiency in delivering genes into cells
5.2.3. Application: Potential adoption of gene therapy as a revolutionary approach to treating cardiovascular diseases
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Gene Therapy Market, by Type
6.1. Introduction
6.2. Antigen Gene Therapy
6.3. Cancer Gene Therapy
6.4. Cytokine Gene Therapy
6.5. Suicide Gene Therapy
6.6. Tumor Suppressor Gene Therapy
7. Gene Therapy Market, by Vector Type
7.1. Introduction
7.2. Non-viral Vectors
7.3. Viral Vectors
8. Gene Therapy Market, by Application
8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Genetic Diseases
8.4. Infectious Diseases
8.5. Neurological Diseases
8.6. Oncological Disorders
9. Americas Gene Therapy Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Gene Therapy Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Gene Therapy Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing
12.3.2. Laurus to launch Gene Therapy Assets in India
12.3.3. Bluebird bio Lays Gene Therapy Launch Groundwork As Sickle Cell Application Nears
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. GENE THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GENE THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GENE THERAPY MARKET DYNAMICS
FIGURE 7. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GENE THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES GENE THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. GENE THERAPY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. GENE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GENE THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENE THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GENE THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS GENE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. CANADA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. CANADA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. CANADA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 60. CANADA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 61. CANADA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. CANADA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. MEXICO GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. MEXICO GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. MEXICO GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 66. MEXICO GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 67. MEXICO GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. MEXICO GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES GENE THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES GENE THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. CHINA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. CHINA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. CHINA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 94. CHINA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 95. CHINA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. CHINA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. INDIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. INDIA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. INDIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 100. INDIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 101. INDIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. INDIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. JAPAN GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. JAPAN GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. JAPAN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 112. JAPAN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 113. JAPAN GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. JAPAN GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. THAILAND GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. THAILAND GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. THAILAND GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 148. THAILAND GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 149. THAILAND GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. THAILAND GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 165. DENMARK GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. DENMARK GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. DENMARK GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 168. DENMARK GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 169. DENMARK GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. DENMARK GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. EGYPT GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. EGYPT GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. EGYPT GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 174. EGYPT GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 175. EGYPT GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. EGYPT GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. FINLAND GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. FINLAND GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. FINLAND GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 180. FINLAND GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 181. FINLAND GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. FINLAND GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. FRANCE GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. FRANCE GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. FRANCE GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 186. FRANCE GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 187. FRANCE GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. FRANCE GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. GERMANY GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. GERMANY GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. GERMANY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 192. GERMANY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 193. GERMANY GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. GERMANY GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. ITALY GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. ITALY GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. ITALY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 204. ITALY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 205. ITALY GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. ITALY GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. NORWAY GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. NORWAY GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. NORWAY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 222. NORWAY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 223. NORWAY GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. NORWAY GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. POLAND GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. POLAND GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. POLAND GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 228. POLAND GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 229. POLAND GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. POLAND GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. QATAR GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. QATAR GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. QATAR GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 234. QATAR GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 235. QATAR GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. QATAR GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SPAIN GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SPAIN GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SPAIN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 258. SPAIN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 259. SPAIN GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SPAIN GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 265. SWEDEN GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. SWEDEN GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 271. SWITZERLAND GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. SWITZERLAND GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. TURKEY GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. TURKEY GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. TURKEY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 276. TURKEY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 277. TURKEY GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. TURKEY GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2024-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. GENE THERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 292. GENE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Abeona Therapeutics Inc.
  • Adaptimmune Therapeutics PLC
  • AGC Biologics.
  • Alnylam Pharmaceuticals, Inc.
  • American Gene Technologies Inc.
  • Amgen Inc.
  • AnGes, Inc.
  • Applied Genetic Technologies Corporation
  • Astellas Gene Therapies
  • Biogen Inc.
  • Bluebird Bio, Inc.
  • Cellectis, Inc.
  • Editas Medicine, Inc.
  • Human Stem Cells Institute
  • Ionis Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Mustang Bio
  • Novartis AG
  • Orchard Therapeutics PLC
  • Poseida Therapeutics, Inc.
  • Sangamo Therapeutics, Inc.
  • Sarepta Therapeutics, Inc.
  • Shenzhen SiBiono GeneTech Co. Ltd.
  • Spark Therapeutics, Inc.
  • Uniqure N.V.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 30.48 Billion
Compound Annual Growth Rate27.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Cell & Gene Therapy Manufacturing Services Market by Type (Cell Therapy, Gene Therapy), Indication (Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases), Application, End-User - Forecast 2024-2030 - Product Image

Global Cell & Gene Therapy Manufacturing Services Market by Type (Cell Therapy, Gene Therapy), Indication (Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases), Application, End-User - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Global Gene Therapy Market Size, Share & Trends Analysis Report by Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), Vector Type (Lentivirus, Adenovirus), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Gene Therapy Market Size, Share & Trends Analysis Report by Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), Vector Type (Lentivirus, Adenovirus), Region, and Segment Forecasts, 2024-2030

  • Report
  • 162 Pages
  • Global
From
Global Cell & Gene Therapy Biomanufacturing CDMO Market by Component (Cell Therapy, Plasmid DNA, Viral Vector), Phase (Phase 1, Phase 2, Phase 3), Indication - Forecast 2024-2030 - Product Image

Global Cell & Gene Therapy Biomanufacturing CDMO Market by Component (Cell Therapy, Plasmid DNA, Viral Vector), Phase (Phase 1, Phase 2, Phase 3), Indication - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area (Neurology, Oncology), Delivery Method (In-vivo, Ex-vivo), RoA (Intravenous) & Region - Global Forecast to 2028 - Product Image

Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area (Neurology, Oncology), Delivery Method (In-vivo, Ex-vivo), RoA (Intravenous) & Region - Global Forecast to 2028

  • Report
  • 276 Pages
  • Global
From
Cell and Gene Therapy Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031 - Product Image

Cell and Gene Therapy Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031

  • Report
  • 115 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.